WuXi begins construction on $150m disposable biomanufacturing site in China

By Zachary Brennan contact

- Last updated on GMT

WuXi begins construction on $150m disposable biomanufacturing site in China

Related tags: Biotechnology, Manufacturing, Cell culture, Wuxi

WuXi PharmaTech subsidiary WuXi Biologics has begun construction on a new $150m biologics manufacturing facility in Wuxi, China, which is expected to be the largest mammalian cell culture manufacturing sire using disposable bioreactors in the world.

To be completed by January 2017, the new facility will also be the largest biologics manufacturing facility in China. This added capacity will support WuXi's biologics manufacturing pipeline in the near term.

The new facility will house fourteen 2000L disposable bioreactors for fed-batch cell culture and two 1000L bioreactors for perfusion runs. The facility will also be built to run advanced continuous or semi-continuous manufacturing processes in addition to traditional fed-batch and perfusion modes. 

This facility further expands WuXi's biologics manufacturing capabilities, which also includes biologics clinical drug substance and drug product manufacturing facilities in Wuxi city, which meet cGMP standards of the US, EU and China.

 Ge Li, Chairman and CEO of WuXi PharmaTech, who recently put forth a bid to take the contract developer and manufacturer private​, noted: "This project continues to strengthen WuXi's capabilities in integrated biologics discovery, development, and manufacturing services. We maintain the highest quality standards to expedite global development of biologics for both international clients and Chinese companies​."

Related news

Show more

Related products

Liposomal and Nanoparticle Technology

Liposomal and Nanoparticle Technology

Pfizer CentreOne | 18-Nov-2022 | Technical / White Paper

Medical science is continuously searching for better ways to administer drugs into the body and to maximize the therapeutic effectiveness of the drugs...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars